Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522077 · ClinicalTrials.gov registry record · NA
RAVE: Radial Artery Vascular Complication and Resource Utilization
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT03522077 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 300 participants.
The verdict
NCT03522077, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if there is a reduction in time to hemostasis in subjects treated with SoftSeal®-STF hemostatic pad when used in conjunction with a vascular compression device after radial transcatheter procedure.
Interventions
- DEVICE RadAR EasyCLik plus ®-STF hemostatic pad
- DEVICE TR BAND® Compression device plus ®-STF hemostatic pad
- DEVICE SoftSeal®-STF hemostatic pad
- DEVICE VascBand™ Hemostat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-05-09 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03522077
The ClinicalTrials.gov registry entry for NCT03522077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which RadAR EasyCLik plus ®-STF hemostatic pad is the first listed.
NCT03522077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03522077 about?
NCT03522077 is a clinical study titled "RAVE: Radial Artery Vascular Complication and Resource Utilization". The primary objective of this study is to determine if there is a reduction in time to hemostasis in subjects treated with SoftSeal®-STF hemostatic pad when used in conjunction with a vascular compression device after radial transcatheter procedure.
What is the current status of trial NCT03522077?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2018-05-09. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT03522077?
The interventions under investigation include: RadAR EasyCLik plus ®-STF hemostatic pad (DEVICE), TR BAND® Compression device plus ®-STF hemostatic pad (DEVICE), SoftSeal®-STF hemostatic pad (DEVICE), VascBand™ Hemostat (DEVICE).
Who is sponsoring clinical trial NCT03522077?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.